Ken Griffin Aptargroup, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Aptargroup, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 3,600 shares of ATR stock, worth $607,428. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,600

Previous 4,800 25.0%

Holding current value

$607,428

Previous $675,000 14.67%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$138.54 - $160.11 $672,473 - $777,173	4,854 Added 87.48%	10,403 $1.67 Million
Q2 2024 Aug 14, 2024	BUY	$137.2 - $150.79 $761,322 - $836,733	5,549 New	5,549 $781,000
Q4 2023 Feb 14, 2024	SELL	$121.17 - $128.59 $4.05 Million - $4.3 Million	-33,403 Reduced 49.72%	33,775 $4.18 Million
Q3 2023 Nov 14, 2023	SELL	$112.47 - $132.89 $9.64 Million - $11.4 Million	-85,668 Reduced 56.05%	67,178 $8.4 Million
Q2 2023 Aug 14, 2023	BUY	$112.49 - $121.7 $13.1 Million - $14.1 Million	116,235 Added 317.49%	152,846 $17.7 Million
Q1 2023 May 15, 2023	BUY	$109.21 - $120.25 $3.42 Million - $3.76 Million	31,275 Added 586.11%	36,611 $4.33 Million
Q4 2022 Feb 14, 2023	SELL	$93.98 - $110.93 $14,566 - $17,194	-155 Reduced 2.82%	5,336 $586,000
Q3 2022 Nov 14, 2022	SELL	$95.03 - $112.07 $1.15 Million - $1.36 Million	-12,117 Reduced 68.82%	5,491 $522,000
Q2 2022 Aug 15, 2022	SELL	$94.77 - $121.41 $8.88 Million - $11.4 Million	-93,736 Reduced 84.19%	17,608 $1.82 Million
Q1 2022 May 16, 2022	SELL	$110.19 - $123.68 $2.34 Million - $2.63 Million	-21,231 Reduced 16.01%	111,344 $13.1 Million
Q4 2021 Feb 14, 2022	BUY	$113.67 - $134.45 $6.8 Million - $8.04 Million	59,780 Added 82.12%	132,575 $16.2 Million
Q3 2021 Nov 15, 2021	BUY	$119.35 - $141.18 $5.51 Million - $6.52 Million	46,195 Added 173.67%	72,795 $8.69 Million
Q2 2021 Aug 16, 2021	SELL	$140.1 - $157.56 $3.64 Million - $4.1 Million	-26,011 Reduced 49.44%	26,600 $3.75 Million
Q1 2021 May 17, 2021	SELL	$128.28 - $144.82 $3.97 Million - $4.49 Million	-30,970 Reduced 37.05%	52,611 $7.45 Million
Q4 2020 Feb 16, 2021	SELL	$112.34 - $136.89 $7.68 Million - $9.36 Million	-68,366 Reduced 44.99%	83,581 $11.4 Million
Q3 2020 Nov 16, 2020	SELL	$112.1 - $122.26 $32.6 Million - $35.5 Million	-290,476 Reduced 65.66%	151,947 $17.2 Million
Q2 2020 Aug 14, 2020	BUY	$94.19 - $113.58 $23.1 Million - $27.9 Million	245,710 Added 124.91%	442,423 $49.5 Million
Q1 2020 May 15, 2020	BUY	$83.93 - $118.22 $5.17 Million - $7.28 Million	61,553 Added 45.54%	196,713 $19.6 Million
Q4 2019 Feb 14, 2020	BUY	$108.22 - $119.25 $14.2 Million - $15.7 Million	131,485 Added 3577.82%	135,160 $15.6 Million
Q3 2019 Nov 14, 2019	SELL	$116.48 - $125.92 $3.62 Million - $3.91 Million	-31,050 Reduced 89.42%	3,675 $435,000
Q2 2019 Aug 14, 2019	BUY	$107.22 - $124.34 $2.3 Million - $2.67 Million	21,471 Added 162.0%	34,725 $4.32 Million
Q1 2019 May 15, 2019	BUY	$89.09 - $106.39 $894,730 - $1.07 Million	10,043 Added 312.77%	13,254 $0
Q4 2018 Feb 14, 2019	SELL	$89.7 - $108.15 $33,099 - $39,907	-369 Reduced 10.31%	3,211 $302,000
Q3 2018 Nov 13, 2018	SELL	$93.29 - $111.97 $23.1 Million - $27.8 Million	-247,887 Reduced 98.58%	3,580 $0
Q2 2018 Aug 10, 2018	BUY	$87.93 - $96.13 $21.7 Million - $23.7 Million	246,668 Added 5139.99%	251,467 $0
Q1 2018 May 11, 2018	SELL	$81.38 - $91.83 $1.75 Million - $1.98 Million	-21,554 Reduced 81.79%	4,799 $431,000
Q4 2017 Feb 09, 2018	BUY	$84.76 - $89.2 $1.6 Million - $1.68 Million	18,830 Added 250.3%	26,353 $2.27 Million
Q3 2017 Nov 09, 2017	BUY	$80.93 - $87.08 $608,836 - $655,102	7,523	7,523 $649,000

Others Institutions Holding ATR

# of Institutions

494

Shares Held

60.5M

Call Options Held

8.3K

Put Options Held

6.8K

View Full List

About APTARGROUP, INC.

Ticker ATR
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 65,337,000
Market Cap $11B
Description
AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps...

More about ATR

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account